Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04711161
Title First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Green3Bio, Inc.

fallopian tube cancer

peritoneum cancer

ovarian cancer



GRN-300 + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.